We are live on ! Find out more
IBER.U

Ibere Pharmaceuticals Units

Delisted

IBER.U was delisted on the 1st of March, 2023.

18 hedge funds and large institutions have $29.5M invested in Ibere Pharmaceuticals Units in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,243% more capital inflows, than outflows

Capital inflows: $12.8M | Capital outflows: $953K

0% more funds holding

Funds holding: 18 → 18 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IBER.U Hedge Fund Activity: Q2 2022 in Review

18 of the 5,965 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units (IBER.U) for Q2 2022, worth a combined $29.5M — up 67% from $17.7M a quarter earlier.

Fund positioning in IBER.U was balanced in Q2 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 5 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $104K. The largest seller was Magnetar Financial, cutting an estimated $623K.

  • 18 institutional investors held Ibere Pharmaceuticals Units (IBER.U) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $29.5M of Ibere Pharmaceuticals Units stock for Q2 2022, up 67% quarter-over-quarter.
  • 2 funds opened new Ibere Pharmaceuticals Units positions in Q2 2022 and 2 closed out, a net change of 0 holders.
  • The largest Ibere Pharmaceuticals Units buyer in Q2 2022 was Susquehanna International Group, an estimated $104K added.
  • The largest Ibere Pharmaceuticals Units seller in Q2 2022 was Magnetar Financial, an estimated $623K sold.

Based on aggregated 13F filings for Q2 2022.